A/Prof Pablo Fernandez-Peñas was invited to attend the 7th Annual Meeting of the Asian Society for Pigment Cell Researchin Shanghai (China). He reviewed our papers on the Cutaneous Side Effects of BRAF inhibitors, MEK inhibitors, anti-CTLA4 and anti-PD1 therapies (Publications) and new results not yet published. Although melanoma is not as a big issue in most Asian countries as it is in Australia, there are patients with metastatic melanoma that will benefit from these drugs and from clinicians being aware of the side effects and mechanisms behind them. All presentations had double projection with slides in English and Mandarin.
Westmead Dermatology
Striving towards disease-free skin
